StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Sangamo Therapeutics's price to book ratio was 21.4× on Jan 30, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.4×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202621.4×+4.8
2025Dec 31, 202516.7×+11.6
2024Dec 31, 20245.1×+4.4
2023Dec 29, 20230.7×−0.8
2022Dec 30, 20221.5×−1.1
2021Dec 31, 20212.7×−1.2
2020Dec 31, 20203.8×+1.7
2019Dec 31, 20192.2×−0.9
2018Dec 31, 20183.1×−4.3
2017Dec 29, 20177.4×+5.9
2016Dec 30, 20161.5×−1.6
2015Dec 31, 20153.1×−1.8
2014Dec 31, 20144.9×−1.8
2013Dec 31, 20136.8×+2.0
2012Dec 31, 20124.8×+3.0
2011Dec 30, 20111.8×–

More Sangamo Therapeutics figures

See a number that looks wrong?